Erratum in Catley et al. Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

In the article by Catley et al entitled “Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells,” which appeared in the November 15, 2006, issue of Blood (Volume 108:3441-3449), Figures 5 and 7 should have been in color, as shown below.